Enliven Therapeutics ELVN
NASDAQ ELVN
$46.97 +0.76 (+1.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Property, Plant & Equipment (Net) (2019 - 2026)

Updated

Enliven Therapeutics (ELVN) reported Property, Plant & Equipment (Net) of $140,000 for Q2 2026, down 69.7% from $462,000 a year earlier but up 600.0% from the prior quarter.

Analysis

Enliven Therapeutics (ELVN) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

At the end of FY2025, Enliven Therapeutics posted Property, Plant & Equipment (Net) of $34,000, down 92.6% from FY2024.

  • Property, Plant & Equipment (Net) has declined for three consecutive years, with a five-year compound annual growth rate of -37.2% (FY2020 to FY2025).
  • By year, Property, Plant & Equipment (Net) came in at $458,000 in FY2024 (-38.3%), $742,000 in FY2023 (-16.6%), $890,000 in FY2022 (+256.0%) and $250,000 in FY2021 (-28.4%).
  • Five-year quarterly Property, Plant & Equipment (Net) spans a low of $20,000 in Q1 2026 and a high of $890,000 in Q4 2022.
  • Year over year, Property, Plant & Equipment (Net) has now declined in each of the last 11 quarters, with an average decline of 52.8% over the last eight quarters.
  • The high point for year-over-year Property, Plant & Equipment (Net) in five years was Q2 2023 (growth of 725.7%); the low point was Q1 2026 (a decline of 95.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20,000 (Q1 2026), $34,000 (Q4 2025) and $399,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Enliven Therapeutics 3.44 Bn 3.44 Bn - 140,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140,000.00
Mar 31, 2026 20,000.00
Dec 31, 2025 34,000.00
Sep 30, 2025 399,000.00
Jun 30, 2025 462,000.00
Mar 31, 2025 404,000.00
Dec 31, 2024 458,000.00
Sep 30, 2024 549,000.00
Jun 30, 2024 630,000.00
Mar 31, 2024 683,000.00
Dec 31, 2023 742,000.00
Sep 30, 2023 806,000.00
Jun 30, 2023 867,000.00
Mar 31, 2023 853,000.00
Dec 31, 2022 890,000.00
Jun 30, 2022 105,000.00
Mar 31, 2022 588,000.00
Dec 31, 2021 250,000.00
Sep 30, 2021 275,000.00
Jun 30, 2021 299,000.00
API Access

Enliven Therapeutics Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=ELVN&period=max&api_key=YOUR_API_KEY